Clinical Trial 49277

Las vegas, NV 89119


Summary:

The VICTORION-2 PREVENT Study is testing an investigational drug to see whether it could help reduce the risk of future cardiovascular events, such as strokes and heart attacks, in people with cardiovascular disease (CVD).  The investigation drug was just FDA approved in January 2022



Criteria:

If you are interested in taking part in the VICTORION-2 PREVENT Study, we’re searching for people who:

·       Are 40 years of age and older

·       Have previously experienced a heart attack, stroke or reduced blood flow to limbs caused by narrowed arteries (peripheral arterial disease)

·       Are currently receiving a high-intensity statin (medication that lowers the level of harmful cholesterol in the blood)

There are other criteria that you will need to meet to qualify for participation in this study, which the study team can discuss with you.  


Qualified Participants May Receive:

Study Related Exams

Study Related medication

Cholesterol background medication if you meet certain criteria

Reimbursement for travel

Friendly staff

 


Available At:

AB Clinical Trials
2110 east flamingo road suite 103
Las vegas, NV 89119
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.